Collins Helen Louise

Director, CHIEF MEDICAL OFFICER, Chief Medical Officer, EVP and Chief Medical Officer, SVP and Chief Medical Officer · SEC CIK 1701247
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$4.89M
14 trades
Net flow
−$4.89M
Net selling
Total filings
50
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed May 20, 2026 ΔOwn −12%

Collins Helen Louise sold $137.4K of ELVN, trimming their stake 12%.

−$137.4K
3,475 sh @ $40
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed May 20, 2026 ΔOwn −4.9%

Collins Helen Louise sold $52.4K of ELVN, trimming their stake 5%.

−$52.4K
1,302 sh @ $40
Advertisement
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Apr 21, 2026 ΔOwn −8.1%

Collins Helen Louise sold $114.6K of ELVN, trimming their stake 8%.

−$114.6K
2,419 sh @ $47
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Apr 21, 2026 ΔOwn −8.9%

Collins Helen Louise sold $117.3K of ELVN, trimming their stake 9%.

−$117.3K
2,441 sh @ $48
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Mar 27, 2026 ΔOwn −62%

Collins Helen Louise sold $1.4M of ELVN, trimming their stake 62%.

−$1.4M
40,000 sh @ $35
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Mar 19, 2026 ΔOwn −17%

Collins Helen Louise sold $138.8K of ELVN, trimming their stake 17%.

−$138.8K
5,000 sh @ $28
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Mar 11, 2026 ΔOwn −29%

Collins Helen Louise sold $305.8K of ELVN, trimming their stake 29%.

−$305.8K
10,129 sh @ $30
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Mar 11, 2026 ΔOwn −54%

Collins Helen Louise sold $896.8K of ELVN, trimming their stake 54%.

−$896.8K
29,871 sh @ $30
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Feb 19, 2026 ΔOwn −64%

Collins Helen Louise sold $1.18M of ELVN, trimming their stake 64%.

−$1.18M
45,000 sh @ $26
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Oct 22, 2024 ΔOwn −100%

Collins Helen Louise sold $24.5K of ELVN, trimming their stake 100%.

−$24.5K
816 sh @ $30
ELVN
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Apr 15, 2024 ΔOwn −100%

Collins Helen Louise sold $501.5K of ELVN, trimming their stake 100%.

−$501.5K
20,000 sh @ $25

Frequently asked questions

How is Collins Helen Louise's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Collins Helen Louise's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.